Benign Epithelial Tumors
Benign epithelial tumors are a group of lesions caused by excessive but fully controlled growth of keratinocytes or of skin appendages (sweat glands, sebaceous glands, hair follicles). Unlike malignant tumors, their cells keep normal polarity, the basement membrane zone (BMZ) stays intact, and they cannot invade the deep dermis or metastasize.
Keratinocyte Growth and Molecular Signaling
- Age-related gene mutations: In seborrheic keratosis (SK), molecular studies have found very frequent somatic mutations in FGFR3 (fibroblast growth factor receptor 3) and PIK3CA (phosphoinositide 3-kinase).
- How the cells divide: Constant activation of FGFR3 switches on the RAS-RAF-MEK-ERK (MAPK) pathway and speeds up division of basal keratinocytes. However, because the p53 tumor suppressor and contact inhibition still work normally, the cells do not cross the basement membrane.
Key Histologic Differences
- Intact basement membrane zone (BMZ): The basement membrane acts as an effective physical and chemical barrier. Tumor cells do not secrete invasive proteolytic enzymes such as MMP-2 or MMP-9.
- Complete differentiation: Although cell numbers increase, keratin production, desmosome formation and maturation into a cornified layer all proceed normally (producing the characteristic horn cysts).
Building on a detailed understanding of keratinocyte growth and the intact basement membrane in benign epithelial tumors, Haute-Derma treats them according to three principles: precise lesion-by-lesion diagnosis, removal that spares healthy tissue, and prevention of recurrence and abnormal scarring:
Microsurgical and Advanced Laser Treatment at Haute-Derma
At Haute-Derma, benign epithelial tumors are treated on the principle of "complete removal, optimal cosmetic outcome, no raised or depressed scars":
Screening With Dermoscopy and High-Frequency Skin Ultrasound
- Digital dermoscopy: assesses pigment patterns and identifies hallmark benign features (milia-like cysts, comedo-like openings) to reliably exclude amelanotic melanoma or pigmented BCC.
- High-frequency skin ultrasound: precisely measures the depth, volume and deep margin of epidermoid and trichilemmal cysts before surgery, avoiding rupture of the cyst wall and prolonged inflammation.
Precise Removal Tailored to Tumor Size and Type
- Micro-spot ablation with Er:YAG 2940 nm / CO2 Superpulse 10,600 nm laser:
- Indications: seborrheic keratosis (SK), syringoma, acrochordon (skin tags).
- Technique: a CO2 Superpulse beam with a very small spot (0.1–0.2 mm) vaporizes the abnormal keratinocytes layer by layer through photocoagulation, without spreading heat into the surrounding healthy tissue (minimizing the risk of post-inflammatory hyperpigmentation, PIH).
- Minimal-incision micro-cystectomy:
- Indications: epidermoid cysts, trichilemmal cysts.
- Technique: a 2–3 mm micro-incision is made at the punctum, and microsurgical instruments are used to remove the entire intact capsule without rupturing the keratin sac. Complete removal of the cyst wall brings the recurrence rate down to 0%.
Barrier Repair and Scar Prevention After Treatment
- Reducing redness and new vessels: Vbeam Perfecta pulsed dye laser (595 nm) is applied once the post-laser crusts have shed, sealing inflammatory new vessels and preventing persistent redness and hypertrophic scarring.
- Deep regenerative infusion: stem cell exosomes plus salmon DNA PDRN are micro-injected around the wound edge to stimulate orderly type I/III collagen production and smoothly fill the defect.
- Surface protection: a biocompatible silicone gel with growth factors (EGF/FGF) is applied, together with a dual-filter mineral sunscreen (zinc oxide).
